Using the molecular classification of glioblastoma to inform personalized treatment

E-ISSN： 1555-2039|232|2|165-177

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.232, Iss.2, 2014-01, pp. : 165-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 7, 2015-10 ,pp. : 1010-1022

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular monitoring of chronic myeloid leukemia: a personalized approach to optimizing treatment response

By Nichols Linda Pippins Julie Castle Lon Cassler Mary Fuller Courtney

Personalized Medicine, Vol. 9, Iss. 7, 2012-09 ,pp. : 727-737

Future Medicine

Access to resources Recommend Favorite

Role of nanobiotechnology in the personalized management of glioblastoma multiforme

By Jain Kewal K

Nanomedicine, Vol. 6, Iss. 3, 2011-04 ,pp. : 411-414

Future Medicine

Access to resources Recommend Favorite

Personalized Treatment of Colorectal Cancer

Oncology Research and Treatment, Vol. 35, Iss. 1, 2012-01 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

Pharmacogenomic biomarkers for personalized cancer treatment

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 2, 2015-02 ,pp. : 201-217

John Wiley & Sons Inc

Access to resources Recommend Favorite